A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

February 8, 2023

Primary Completion Date

September 30, 2026

Study Completion Date

October 31, 2026

Conditions
OverweightObesityChronic Kidney DiseaseType 2 DiabetesT2D
Interventions
DRUG

Tirzepatide

Administered SC

DRUG

Placebo

Administered SC

Trial Locations (27)

1030

Klinik Landstraße, Vienna

1060

Zentrum für klinische Studien Dr Hanusch Gmbh, Vienna

1130

Klinik Hietzing, Vienna

8200

Aarhus Universitetshospital, Skejby, Aarhus

14080

Instituto Nacional de Cardiologia Ignacio Chavez, México

46123

American Health Network of Indiana, LLC - Avon, Avon

46140

American Health Network of Indiana, LLC - Greenfield, Greenfield

46202

Indiana University Health University Hospital, Indianapolis

47304

American Health Network of Indiana, LLC - Muncie, Muncie

48098

Arcturus Healthcare , PLC, Troy Internal Medicine Research Division, Troy

62448

Investigación Nefrológica, Cuernavaca

80045

University of Colorado Anschutz Medical Campus, Aurora

80210

Kidney Associates of Colorado, Denver

91325

Valley Clinical Trials, Inc., Northridge

98195

University of Washington Medical Center - Montlake, Seattle

99204

Providence Medical Research Center - Spokane, Spokane

L4N 7L3

LMC Clinical Research Inc. (Barrie), Barrie

L4K 4M2

LMC Clinical Research Inc. (Thornhill), Concord

J1H 5N4

Centre intégré universitaire de santé et de services sociaux de l'Estrie Centre Hospitalier Universitaire -T, Sherbrooke

M5G 2C4

Toronto General Hospital, Toronto

N2J 1C4

Fadia El Boreky Medicine, Waterloo

06700

Centro de Investigación y Gastroenterología, Cuauhtémoc

03100

Health Pharma Professional Research S.A. de C.V:, Mexico City

03310

Grupo Medico Camino Sc, Mexico City

06760

Caimed Investigacion En Salud S.A. de C.V., Mexico City

7609 PP

Ziekenhuisgroep Twente, locatie Almelo, Almelo

1081 HV

Amsterdam UMC, locatie VUmc, Amsterdam

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY